<DOC>
	<DOCNO>NCT01808118</DOCNO>
	<brief_summary>This Multicenter , randomize , double-blind study subject moderate severe non-radiographic Axial Spondyloarthritis . There 28-week open-label period follow 40-week double-blind , placebo-controlled period subject meet randomization criterion . Subjects flare double-blind period opportunity receive least 12-weeks rescue therapy .</brief_summary>
	<brief_title>Study Comparing Efficacy Safety Continuing Versus Withdrawing Adalimumab Therapy Maintaining Remission Subjects With Non-Radiographic Axial Spondyloarthritis</brief_title>
	<detailed_description />
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Adult subject inadequate response &gt; /= 2 nonsteroidal antiinflammatories ( NSAIDs ) Subject axial SpA fulfil Assessment Spondyloarthritis international Society ( ASAS ) axial SpA classification criterion Subject evidence active inflammation sacroiliac ( SI ) joint spine MRI , elevate hsCRP Negative TB screen assessment Ability administer subcutaneous injection General good health otherwise Prior antiTumor Necrosis Factor ( TNF ) therapy ; biologic therapy potential therapeutic impact SpA treat investigational drug chemical biologic nature within 30 day 5 halflives baseline . Fulfillment radiographic criterion modify New York criterion Ankylosing Spondylitis Recent infection require treatment Significant medical event condition may put patient risk participation Female subject pregnant breastfeed consider become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Musculoskeletal Diseases</keyword>
	<keyword>Joint Diseases</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Spondylarthropathy</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Anti-Inflammatory Agents</keyword>
	<keyword>Spondyloarthritis</keyword>
	<keyword>Spinal Diseases</keyword>
	<keyword>Antirheumatic Agents</keyword>
	<keyword>Ankylosing Spondyloarthritis</keyword>
	<keyword>Spondylitis</keyword>
</DOC>